Search research articles
Contact Us
Filters
Showing results (171-180 of 214) with videos related to
Page
of 22
Sort By:
Clinical Epidemiology
|
November 18, 2020
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis
Mei Lu, Christopher L Bowlus, Keith Lindor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)
Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Journal of Hepatology
|
March 4, 2015
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J Gane, Young-Suk Lim, Stuart C Gordon, et al.
Journal of Hepatology
|
March 20, 2018
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis
Massimo Puoti, Graham R Foster, Stanley Wang, et al.
Hepatology (Baltimore, Md.)
|
November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure
Fred Poordad, Stanislas Pol, Armen Asatryan, et al.
Journal of Hepatology
|
December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients
W Ray Kim, Thomas Berg, Tarik Asselah, et al.
Gastroenterology
|
May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevir
Fred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 27, 2017
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment
Mei Lu, Yueren Zhou, Irina V Haller, et al.
Hepatology Communications
|
April 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies
Stuart C Gordon, Alejandra Villamil, Ira M Jacobson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis
Adrielly Martins, Anish Reddy, Richard Dean, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 214) with videos related to
Sort By:
Page
of 22
Clinical Epidemiology
|
November 18, 2020
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis
Mei Lu, Christopher L Bowlus, Keith Lindor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)
Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Journal of Hepatology
|
March 4, 2015
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J Gane, Young-Suk Lim, Stuart C Gordon, et al.
Journal of Hepatology
|
March 20, 2018
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis
Massimo Puoti, Graham R Foster, Stanley Wang, et al.
Hepatology (Baltimore, Md.)
|
November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure
Fred Poordad, Stanislas Pol, Armen Asatryan, et al.
Journal of Hepatology
|
December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients
W Ray Kim, Thomas Berg, Tarik Asselah, et al.
Gastroenterology
|
May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevir
Fred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 27, 2017
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment
Mei Lu, Yueren Zhou, Irina V Haller, et al.
Hepatology Communications
|
April 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies
Stuart C Gordon, Alejandra Villamil, Ira M Jacobson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis
Adrielly Martins, Anish Reddy, Richard Dean, et al.
Page
of 22